/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

Emerald Development Managers
New YorkSeed–Series A
9 people
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
Cultivian Sandbox Ventures
ChicagoSeed–Late Stage$5M – $15M
8 people
iNetworks
PittsburghSeed–Late Stage
11 people
Pathway to Cures
New YorkSeed–Series A
17 people
Han River Partners
Menlo ParkSeed–Series A
13 people
Animal Capital
RaleighPre-Seed–Series B$100K – $1M
9 people
MRL Ventures Fund
CambridgePre-Seed–Series A$25M
6 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries B–Late Stage
15 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Kaleida Capital
San Diego
14 people
FemHealth Ventures
Short HillsSeed–Series A
10 people
Helm
New York CityPre-Seed–Series A$500K
4 people
VanEck
New YorkPre-Seed–Series A
13 people
American Century Private Investments
Kansas CityGrowth
18 people
Black Flag
San DiegoPre-Seed–Seed$250K – $5M
6 people
Moth Fund
San FranciscoPre-Seed–Seed
3 people
Scion Life Sciences
New YorkSeed–Late Stage$1K – $60M
12 people
Mithril Capital Management
AustinSeries B–Growth
5 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Riverfront Ventures, LLC
PittsburghSeed–Series A$250K – $1M
8 people
Character
MilwaukeePre-Seed–Seed$200K – $2M
4 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
4 people
Parallel 18
San JuanPre-Seed–Growth
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.